The expression of PDL1 in tumor cells could be consequence of PDL1 genetic alterations, which were demonstrated in EBV+ DLBCL [31], but also as a result of the activation by LMP1 and EBNA2 viral latent oncogenic proteins [32, 33]. The gene discussed is PDLIM7; the disease is diffuse large B-cell lymphoma.